Neurocrine Biosciences reported new survey and Phase 4 KINECT PRO data indicating that adults with tardive dyskinesia taking INGREZZA experienced fewer work and school disruptions and broad quality of...
Source LinkNeurocrine Biosciences reported new survey and Phase 4 KINECT PRO data indicating that adults with tardive dyskinesia taking INGREZZA experienced fewer work and school disruptions and broad quality of...
Source Link
Comments